A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 539 participants.

Also called NCT02698839

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 539 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02698839
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02698839. Randomized; single masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2018-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
Acronym
RCT
Intervention (Device)
BuMA Supreme
Intervention (Device)
BuMA™
Lead sponsor
Sino Medical Sciences Technology Inc. (class: industry)

Record details

Record id
cardio:ct-nct02698839
Content hash
836d9b8e0eb021235d49e3a5cc6540bd2e5f126a4e0eb8b8e2f6d5222e278462